Cooper Companies to acquire Saulfon Pharmaceuticals for $1.2B The Cooper Companies announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approximately $1.2B. Sauflon forecasts revenue of approximately $210M for FY14, up approximately 22% year-over-year. Excluding one-time charges and deal-related amortization, the transaction is expected to be accretive to EPS in FY15. The acquisition will be financed with off-shore cash and credit facilities.
K2M, Cooper favorite med tech names in current envirnoment, says Piper Jaffray Piper Jaffray analyst Matt O'Brien said that his favorite names in medical technology given the current environment of broader market weakness are K2M Group (KTWO) and Cooper Companies (COO) given their limited exposure to China and the fact that neither has large exposure to big capital equipment purchases or deferrable procedures nor are they in need of capital. O'Brien has Overweight ratings on both stocks.